Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangqiu Li

Showing results (11-20 of 291) with videos related to

Pageof 30
Sort By:
Blood Science (Baltimore, Md.)|April 11, 2022
The disruption of hematopoiesis in tumor progressionXiaofang Wang, Yangqiu Li
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 13, 2023
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignanciesCunte Chen, Yangqiu Li
The Lancet. Oncology|June 9, 2016
Immunotherapy for small-cell lung cancerYangqiu Li, Yi-Long Wu
The Lancet. Oncology|May 25, 2019
The second wave of checkpoint inhibitors with chemotherapy for advanced non-small-cell lung cancerYangqiu Li, Yi-Long Wu
Cell Biology and Toxicology|May 6, 2017
T cell modulation in immunotherapy for hematological malignanciesChen Lin, Shaohua Chen, Yangqiu Li
Journal of Hematology & Oncology|July 6, 2018
T cell senescence and CAR-T cell exhaustion in hematological malignanciesDimitri Kasakovski, Ling Xu, Yangqiu Li
Experimental Hematology & Oncology|December 6, 2012
The role of BCL11B in hematological malignancyXin Huang, Xin Du, Yangqiu Li
Blood Science (Baltimore, Md.)|April 11, 2022
The importance of genomic predictors for clinical outcome of hematological malignanciesCunte Chen, Chengwu Zeng, Yangqiu Li
Cell Regeneration (London, England)|January 24, 2019
Approaches for generation of anti-leukemia specific T cellsZhenyi Jin, Ling Xu, Yangqiu Li
Cancer Cell International|November 9, 2012
The role of A20 in the pathogenesis of lymphocytic malignancyFan Zhang, Lijiang Yang, Yangqiu Li
Pageof 30

Showing results (11-20 of 291) with videos related to

Sort By:
Pageof 30
Blood Science (Baltimore, Md.)|April 11, 2022
The disruption of hematopoiesis in tumor progressionXiaofang Wang, Yangqiu Li
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 13, 2023
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignanciesCunte Chen, Yangqiu Li
The Lancet. Oncology|June 9, 2016
Immunotherapy for small-cell lung cancerYangqiu Li, Yi-Long Wu
The Lancet. Oncology|May 25, 2019
The second wave of checkpoint inhibitors with chemotherapy for advanced non-small-cell lung cancerYangqiu Li, Yi-Long Wu
Cell Biology and Toxicology|May 6, 2017
T cell modulation in immunotherapy for hematological malignanciesChen Lin, Shaohua Chen, Yangqiu Li
Journal of Hematology & Oncology|July 6, 2018
T cell senescence and CAR-T cell exhaustion in hematological malignanciesDimitri Kasakovski, Ling Xu, Yangqiu Li
Experimental Hematology & Oncology|December 6, 2012
The role of BCL11B in hematological malignancyXin Huang, Xin Du, Yangqiu Li
Blood Science (Baltimore, Md.)|April 11, 2022
The importance of genomic predictors for clinical outcome of hematological malignanciesCunte Chen, Chengwu Zeng, Yangqiu Li
Cell Regeneration (London, England)|January 24, 2019
Approaches for generation of anti-leukemia specific T cellsZhenyi Jin, Ling Xu, Yangqiu Li
Cancer Cell International|November 9, 2012
The role of A20 in the pathogenesis of lymphocytic malignancyFan Zhang, Lijiang Yang, Yangqiu Li
Pageof 30